Relative Value Partners Group’s Medical Properties Trust MPT Stock Holding History

Relative Value Partners Group’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.95M	Buy	+452,700	New	+$2.17M	0.25%	93

Other funds holding MPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Relative Value Partners Group's MPT Position: Q2 2024 in Review

Relative Value Partners Group opened a new position in Medical Properties Trust (MPT) in Q2 2024: 452,700 shares worth $1.95M. The stake represents 0.25% of the portfolio and ranks #93 among its holdings.

501 funds tracked by Wall St. Rank hold MPT as of Q2 2024.

Relative Value Partners Group held 452,700 shares of Medical Properties Trust worth $1.95M as of Q2 2024.
Medical Properties Trust was a new Relative Value Partners Group position in Q2 2024.
Medical Properties Trust made up 0.25% of Relative Value Partners Group's portfolio in Q2 2024, its #93 holding.
501 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2024.

Based on Relative Value Partners Group's 13F filing for Q2 2024, filed 12 Jul 2024.